AKAM insider filing: 4,000 shares proposed sale valued $303K
Rhea-AI Filing Summary
Akamai Technologies, Inc. (AKAM) Form 144 shows a proposed insider sale of 4,000 common shares via Charles Schwab & Co., with an aggregate market value of $303,040. The filing lists total outstanding shares of 143,385,528 and an approximate sale date of 08/20/2025. The 4,000 shares were acquired through equity compensation: 2,476 shares from a performance stock lapse on 02/19/2025 and 1,524 shares from a restricted stock lapse on 03/06/2025. No sales in the past three months are reported and the filer certifies no undisclosed material adverse information.
Positive
- None.
Negative
- None.
Insights
TL;DR: Small executive sale notice for 4,000 shares from recent equity vesting; immaterial to overall capitalization.
The Form 144 documents a proposed sale tied to recent equity compensation vesting events totaling 4,000 shares valued at $303,040. Relative to the 143.4 million shares outstanding, the sale size is negligible and appears to be routine monetization of vested equity rather than liquidation of a large stake. The filing reports no prior sales in the past three months, which suggests this is a discrete transaction rather than an ongoing selling program. Impact on share supply and market liquidity is likely minimal.
TL;DR: Disclosure complies with Rule 144 and contains required acquisition/payment details; no governance red flags disclosed.
The notice provides the necessary Rule 144 details: acquisition dates, nature of acquisition (performance stock lapse and restricted stock lapse), broker information, and a certification regarding material nonpublic information. There is no indication of a 10b5-1 plan adoption date in the remarks. From a governance perspective, the form meets regulatory disclosure standards and does not reveal material governance concerns or undisclosed related-party transactions.